-- ボーイング（BA）は水曜日、米陸軍からCH-47F II型チヌークヘリコプター6機の納入に関する3億2400万ドルの契約を受注したと発表した。 「ブロックII型チヌークは、過酷な環境や紛争地域で活動する部隊に対し、作戦範囲の拡大、迅速な補給、そして強化された防御力を提供する」と、ボーイング・ディフェンス・スペース＆セキュリティの貨物プログラム担当副社長兼プログラムマネージャーのヘザー・マクブライアン氏は述べた。 同社はすでに6機のCH-47Fヘリコプターを陸軍に納入しており、陸軍は2028年半ばまでに最初の部隊を配備する準備を進めている、と声明で発表した。
Price: $222.29, Change: $-1.48, Percent Change: -0.66%
(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.
Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.
Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.